Magumun, Francesca Aurea E.

January 15, 2024

Group 3 BSN4-B

Patient Name: Dumama,Niesha Mojares

Drug Study

Drug Name Dosage Route Frequency

Parecoxib 40 mg IV Every 12 hours

Paracetamol 500 mg IV Every 8 hours

Cefuroxime 750 mg IV Every 8 hours

Dexketoprofen 25 mg Per Orem Every 8 hours

Sultamicillin 750 mg Per Orem Every 12 hours for 7 days

Mupirocin Topical Before Bedtime

Levofloxacin 1 Drop Left Eye Ophthalmic Four times daily

Drug 1:Dynastat(Parecoxib) 40 mg IV Every 12 hours

Generic Name Mechanism of Indication Contraindication Side Effects/ Adverse Effects Nursing Responsibilities
Brand Name Action/Classification

Generic: Mechanism of Action: Used for short term -Hypersensitivity to Side Effects: ● Observe the 14 rights in
Parecoxib Parecoxib, a prodrug of perioperative pain parecoxib sodium or ● Jaundice administering the
valdecoxib, is a selective control. valdecoxib., ● Swelling medications
Brand:Dynastat COX-2 inhibitor that Parecoxib should not ● Back Pain ● Monitor Drug Compatibility
exhibits anti-inflammatory, be given to patients ● Rasg ● Keep emergency equipment
Dosage: 40 mg analgesic and antipyretic who have experienced ● High Blood Pressure available
properties. It decreases the asthma, urticaria, or ● Raise side rails as a
Route: IV activity of COX-2 which allergic-type reactions precaution
leads to reduced formation after taking aspirin, Adverse Effects:
Frequency: Every 12 of prostaglandin NSAIDs or other ● Difficulty of
hours precursors, thereby COX-2 specific Breathing
inhibiting prostaglandin inhibitors
synthesis

Classification:
antiinflammatory and
antirheumatic products

Drug 2 : Paracetamol (Ifimol) 500 mg IV every hours

Generic Name Mechanism of Indication Contraindication Side Effects/ Adverse Effects Nursing Responsibilities
Brand Name Action/Classification

Generic: Mechanism of Action: Short-term treatment Hypersensitivity to Side Effects:

Ifimol Paracetamol has a central of moderate pain, paracetamol or ● Stomach pain ● Observe the 14 rights in
analgesic effect that is especially following propacetamol.Severe ● Nausea administering the
Brand: mediated through surgery and for the h hepatocellular ● Vomiting medications
Paracetamol activation of descending Short-term treatment insufficiency. ● Difficulty sleeping ● Assess overall health status
serotonergic pathways. of fever, ● Constipation and alcohol usage before
Dosage: 500 mg Debate exists about its administering acetaminophen
primary site of action, Adverse Effects: ● Assess onset, type, location,
Route: IV which may be inhibition of ● Liver injury duration of pain
prostaglandin (PG) ● Kidney Injury ● Assess for clinical
Frequency: Every 8 synthesis or through an ● Coma improvement and relief of
hours active metabolite pain, fever.
influencing cannabinoid ● Monitor liver function
receptors. studies: AST, ALT, bilirubin
● Check I&O ratio
Classification: ● Monitor the patient’s
Analgesic response to the medication.
● Inform patient that urine may
become dark brown as a
result of phenacetin

Drug 3 : Ciftin (Cefuroxime)

Generic Name Mechanism of Indication Contraindication Side Effects/ Adverse Effects Nursing Responsibilities
Brand Name Action/Classification

Generic: Mechanism of Action: For the treatment of Hypersensitivity to Side Effects: ● Observe the 14 rights in
Cefuroxime Binds to and inhibits the many different types cefuroxime or any ● Nausea administering the medication.
enzyme that cross-links the of bacterial infections other cephalosporins. ● Rash ● Question for history of
Brand peptide chain of the newly ● Dark Urine allergies, particularly
formed ‘building ● Tiredness cephalosporins, penicillins.
Dosage: 750 mg blocks’ to the ● Weakness ● Monitor for vital signs and
peptidoglycan cell wall ● Thrush record.
Route: IV backbone. ● Assess oral cavity for white
patches on mucous
Frequency: Every 8 Classification: Adverse Effects: membranes, tongue (thrush).
hours Third-generation ● Loss of Voice ● Obtain CBC, renal function
cephalosporin b-lactam ● Bacterial tests.
antibiotic superinfection ● Monitor daily pattern of
● Bleeding bowel activity, stool
● Anorexia consistency.
● Decrease HCT ● Observe for any
hypersensitivity reaction.
● Encourage an increase in oral
 fluid intake.
● Instruct to take the
medication religiously. (to
avoid potentials wound
infection )

Drug 4 : Dexketoprofen 25 mg Per Orem Every 8 hours

Generic Name Mechanism of Indication Contraindication Side Effects/ Adverse Effects Nursing Responsibilities
Brand Name Action/Classification

Generic: Dexketoprofen Mechanism of Action:
It is a non-steroidal
Brand: Keprofyn anti-inflammatory drug
(NSAID) that reduces
Dosage:25 mg prostaglandin synthesis via
inhibition of
Route: Per Orem cyclooxygenase pathway
(both COX-1 and COX-2)
Frequency: Every 8 activity
hours
Classification:
NSAID
Used to treat mild to Hypersensitivity to Side Effects: ● Observe the 14 rights in
moderate pain. dexketoprofen, or any ● Nausea administering the
other NSAIDs. History ● Vomiting, medications
of asthma attacks, ● Stomach pain, ● Assess for bowel sounds
bronchospasm, ● Diarrhea, ● Monitor daily pattern of
angioneurotic oedema, ● Dyspepsia bowel activity, stool
acute rhinitis, nasal consistency.
polyps, urticaria, or Adverse Effects: ● Encourage an increase in
other allergic-type ● Thrombocytopenia oral fluid intake.
reaction after taking ● a and anemia with ● Encourage patient to be
aspirin or other bleeding episodes strict on her diet : Soft Diet
NSAIDs ● Document

Drug 5: Unasyn(Sultamicillin) 750 mg Per Orem Every 12 hours for 7 days

 Generic Name Mechanism of Indication Contraindication Side Effects/ Adverse Effects Nursing Responsibilities
Brand Name Action/Classification

Generic: Mechanism of Action:
Sultamicillin
Sultamicillin is a prodrug
Brand:Unasyn of ampicillin and
sulbactam linked as a
Dosage: 750 mg double ester. Ampicillin
prevents bacterial cell wall
Route: Per Orem synthesis by binding to 1
or more of the
Frequency: penicillin-binding proteins
Every 12 hours for 7 resulting in inhibition of
days the final transpeptidation
step of peptidoglycan
synthesis in the bacterial
cell walls. Sulbactam
extends the spectrum of
ampicillin activity due to
its irreversible inhibition
of β-lactamases that are
found in
penicillin-resistant
organisms. It has limited
antibacterial activity to
Neisseriaceae.
Skin and soft tissue Hypersensitivity to Side Effects:
infections, ampicillin, sulbactam, ● Headache ● Observe the 14 rights in
or penicillins. ● Diarrhea, administering the
● Rash medications
● Nausea ● Question for history of
allergies
Adverse Effects: ● Evaluate IV site for phlebitis.
● Thrombophlebitis ● Check the IM injection site
● Seizure for pain induration.
● Severe ● Monitor I&O, urinalysis,
hypersensitivity renal function tests. Be alert
reactions for superinfection:
● Instruct patient Report rash,
diarrhea, or other new
symptoms

Classification: Antibiotiv

Drug 6 : Ketorolac (Trometamol), Every 6 hours per 6 doses

Generic Name Mechanism of Indication Contraindication Side Effects/ Adverse Effects Nursing Responsibilities
 Brand Name Action/Classification

Generic: Mechanism of Action: Intra-Abdominal Patients with a prior Side Effects:

Metronidazole Diffuses into organisms, Infections,Pseudome history of ● Anorexia ● Observe the 14 rights in
interacting with DNA mbranous Colitis hypersensitivity to ● Nausea, administering the
Brand: causing a loss of helical metronidazole or other ● Dry mouth, metallic medications
Flagyl DNA structure and strand nitroimidazole taste ● Obtain baseline CBC, LFT.
Dosage: 500 mg breakage, inhibiting derivatives. ● Vomiting ● Question for history of
protein synthesis. ● Dizziness hypersensitivity
Route: per orem ● Monitor daily pattern of
Classification: Adverse Effects: bowel activity, stool
Frequency: every 8 Antibacterial,Antiprotozoa consistency.
hours l, Amebicide ● Glossitis ● Monitor I&O, assess for
● Cystitis, dysuria, urinary problems.
● Pancreatitis. ● Advised patient that urine
● Peripheral neuropathy may be red-brown

Drug 7 Mupicort (Mupirocin) Topical Before Bedtime :

Generic Name Mechanism of Indication Contraindication Side Effects/ Adverse Effects Nursing Responsibilities
Brand Name Action/Classification

Generic: Mechanism of Action: To treat secondarily contraindicated in Side Effects:

Mupirocin IInhibits bacterial protein, infected traumatic individuals with a ● Headache ● Observe the 14 rights in
Brand: RNA synthesis. Less skin lesions due to history of sensitivity ● Rhinitis administering the
Mupicort effective on DNA specific bacteria. reactions to any of its ● Upper respiratory medications
Dosage: synthesis components congestion ● Assess skin for type, extent
● Pharyngitis, altered of lesions.
Route: Topical Classification: taste. ● Monitor healing of skin
Monocarboxylic acid lesions.stop applications,
Frequency: Before Adverse Effects: cleanse area gently, notify
bedtime ● Infections physician
● Perform Hand-Hygiene
 ● Explain precautions to the
patient to avoid spread of
infection
● Teach patient family on how
to apply for medication

Drug 8 : Levofloxacin 1 Drop Left Eye Ophthalmic Four times daily

 Generic Name Mechanism of Indication Contraindication Side Effects/ Adverse Effects Nursing Responsibilities
Brand Name Action/Classification

Generic: Mechanism of Action: Uncomplicated mild Seizure, Side Effects:

Levofloxacin Inhibits DNA enzyme to moderate skin/ Hypomagnesemia, ● Headache ● Observe the 14 rights in
gyrase in susceptible underlined myasthenia gravis, ● Nausea administering the
Brand: microorganisms, infection,Treatment of Severe cerebral ● Abdominal pain medications
Levox interfering with bacterial superficial infections arteriosclerosis, ● Dizziness ● Place a gloved finger on the
cell replication, repair. to conjunctiva Prolonged QT interval, ● Drowsiness lower eyelid and pull out
Dosage: medication ● headache until a pocket is formed
1 drop left eye Classification: between eye and lower lid.
Route: Fluoroquinolone. Adverse Effects: ● Place a prescribed number of
Optha drops into the pocket.
Frequency: 4 times ● Infection ● Instruct pt to close eye gently
daily ● Confusion ● Question history as listed in
● Agitatiion Precautions.
● Severe Diarrhea ● Receive full medication
history
● Obtain baseline ECG.
● Monitor serum glucose, renal
function, LFT.
● Monitor daily pattern of
bowel activity, stool
consistency
● Instruct patient to report any
symptoms of anxiety,
depression and agitation.
References

Book

(n.d.). DrugBank Online | Database for Drug and Drug Target Info. https://go.drugbank.com/Kizior, R. J., & Hodgson, K. (2022). Saunders nursing drug handbook 2023
- E-book. Elsevier Health Sciences.’

Website

MIMS. (2023). Search drug information. Search Drug Information, Interactions, Images, Dosage & Side Effects | MIMS Philippines.
https://www.mims.com/philippines/drug
Magumun, Francesca Aurea E. January 15, 2024
Group 3 BSN4-B

Patient Name: Dumama,Niesha Mojares

1. RISK FOR DEFICIENT FLUID VOLUME DEFICIT

ASSESSMENT DIAGNOSIS PLANNING INTERVENTION RATIONALE EVALUATION

Subjective Risk for Deficient Short Term Independent Short Term

“ Nagsusuka siya kanina, volume deficit related to After 8 hours of Monitored I&O. Identifies nutritional Goal Met
nakalahati niya itong Postoperative Open nursing intervention Calculate insensible strengths and
basin, Lahat ng tinake Reduction Internal the fluid volume of losses and fluid balance. deficiencies. After 8 hours of
niya isunusuka niya lang Fixation,Right Clavicle the patient will nursing intervention
din “ day 1 gradually increase at Weighed patient Measure of adequacy of the fluid volume of
functional level, fluid replacement and the patient was able to
Objective Cues attain adequate urine kidney funcTion gradually increased at
output functional level,
● Nausea and moderately attain adequate urine
● Pale, Dry Skin improve skin turgor Assessed for bowel output
● Poor Skin and elasticity. sound movement and moderately
Turgor improved skin turgor
● Decreased and elasticity.
Urine Output Long Term Positioned in a modified To promote comfort
● Delayed After four days of side lying position. and prevents aspiration
capillary refill nursing intervention the of vomitus Long Term
● Post operative patient will be able to Goal Met
Open Reduction Identify individual risk After four days of
 Internal factors and appropriate Provided an emesis basin To catch the vomit and nursing intervention the
Fixation,Right interventions. And within easy reach. to prevent spillage patient was able to
Clavicle day 1 Initiate Identify individual risk
behaviors/lifestyle factors and appropriate
changes to prevent Encouraged to limit Abrupt or gross interventions. And
Vital Signs taken as development of deficient physical activities movements may Initiated
follows: volume deficts aggravate the condition behaviors/lifestyle
changes that prevented
Bp 90/70 the development of
Pr: 110 Provided a comfortable To regulate deficient volume deficits.
Rr: 19 environment by adjusting temperature, thus
O2 Sat: 94 the room preventing further fluid
temperature,and covering Loss.
the patient with light
sheets.

Eliminated stimuli that To avoid the patient’s

triggers nausea such as exposure to the stimuli
offending odors (cooking that may worsen
smells, smoke, strong nausea.
perfumes).

Allowed to use non To help the patient

pharmacological nausea control her nausea
control techniques such through diversion
as relaxation, guided techniques.
imagery, music therapy,
distraction, or deep
breathing exercise

Applied lotion to dry To soothe the skin of

areas of the skin. the patient and prevent it
from further drying

Encouraged increased To replace lost fluids.

fluid intake after 24
hour s of oral restriction
as tolerated and advised.

Provided Mouth Care at To reduce discomfort of

least every 4 hours and dry mucous membrane
as needed.

Dependent

Administered IV fluid as To replace fluid loss in

ordered by the physician the body and to prevent
dehydration
Collaboration

Refer patient to dietician To create food plan and

care for the patient
References

Books

Benenson, E. (2013). Syndrome-based approach to diagnosis: A practical guide. Springer Science & Business Media.

Doenges, M. E., Moorhouse, M. F., & Murr, A. C. (2022). Nurse's pocket guide: Diagnoses, prioritized interventions, and rationales. F.A. Davis.

Gulanick, M., & Myers, J. L. (2013). Nursing care plans - E-book: Nursing diagnosis and intervention. Elsevier Health Sciences.

Herdman, H. T., & Kamitsuru, S. (2017). NANDA international nursing diagnoses: Definitions & classification 2018-2020. Thieme.